Sign In to Follow Application
View All Documents & Correspondence

Method For Treating Cancer Using Artificial Adjuvant Vector Cells (A Avc)

Abstract: Provided is a method for treating or preventing cancer safely and effectively using aAVC. Suitable ranges for the dose of a-GalCer loaded on the surface of aAVC cells preferred from the viewpoint of ensuring safety and efficacy in the treatment and prevention of cancer using aAVC and the amount of a-GalCer loaded on the surface of aAVC cells contained in a pharmaceutical composition containing aAVC were discovered, and, inter alia, a method for treating or preventing cancer safely and effectively using aAVC, aAVC for safe and effective treatment or prevention of cancer, and a pharmaceutical composition containing said aAVC are provided.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
20 June 2022
Publication Number
25/2022
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
patent@depenning.com
Parent Application

Applicants

ASTELLAS PHARMA INC.
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
RIKEN
2-1, Hirosawa, Wako-shi, Saitama 3510198

Inventors

1. OHSUMI Keisuke
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
2. YOSHIDA Taku
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
3. KANKI Masayuki
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
4. FUJII Shinichiro
c/o RIKEN, 2-1, Hirosawa, Wako-shi, Saitama 3510198
5. SHIMIZU Kanako
c/o RIKEN, 2-1, Hirosawa, Wako-shi, Saitama 3510198

Specification

Documents

Application Documents

# Name Date
1 202247035149-FORM 3 [30-11-2022(online)].pdf 2022-11-30
1 202247035149.pdf 2022-06-20
2 202247035149-STATEMENT OF UNDERTAKING (FORM 3) [20-06-2022(online)].pdf 2022-06-20
2 202247035149-Correspondence_GPA_20-09-2022.pdf 2022-09-20
3 202247035149-SEQUENCE LISTING(PDF) [20-06-2022(online)].pdf 2022-06-20
3 202247035149-FORM-26 [16-08-2022(online)].pdf 2022-08-16
4 202247035149-SEQUENCE LISTING [20-06-2022(online)].txt 2022-06-20
4 202247035149-Correspondence_Proof of Right (Form 1), POA_04-08-2022.pdf 2022-08-04
5 202247035149-PRIORITY DOCUMENTS [20-06-2022(online)].pdf 2022-06-20
5 202247035149-FORM-26 [18-07-2022(online)].pdf 2022-07-18
6 202247035149-Proof of Right [18-07-2022(online)].pdf 2022-07-18
6 202247035149-FORM 1 [20-06-2022(online)].pdf 2022-06-20
7 202247035149-DRAWINGS [20-06-2022(online)].pdf 2022-06-20
7 202247035149-COMPLETE SPECIFICATION [20-06-2022(online)].pdf 2022-06-20
8 202247035149-DECLARATION OF INVENTORSHIP (FORM 5) [20-06-2022(online)].pdf 2022-06-20
9 202247035149-DRAWINGS [20-06-2022(online)].pdf 2022-06-20
9 202247035149-COMPLETE SPECIFICATION [20-06-2022(online)].pdf 2022-06-20
10 202247035149-FORM 1 [20-06-2022(online)].pdf 2022-06-20
10 202247035149-Proof of Right [18-07-2022(online)].pdf 2022-07-18
11 202247035149-PRIORITY DOCUMENTS [20-06-2022(online)].pdf 2022-06-20
11 202247035149-FORM-26 [18-07-2022(online)].pdf 2022-07-18
12 202247035149-SEQUENCE LISTING [20-06-2022(online)].txt 2022-06-20
12 202247035149-Correspondence_Proof of Right (Form 1), POA_04-08-2022.pdf 2022-08-04
13 202247035149-SEQUENCE LISTING(PDF) [20-06-2022(online)].pdf 2022-06-20
13 202247035149-FORM-26 [16-08-2022(online)].pdf 2022-08-16
14 202247035149-STATEMENT OF UNDERTAKING (FORM 3) [20-06-2022(online)].pdf 2022-06-20
14 202247035149-Correspondence_GPA_20-09-2022.pdf 2022-09-20
15 202247035149.pdf 2022-06-20
15 202247035149-FORM 3 [30-11-2022(online)].pdf 2022-11-30